Previous Article | Next Article 
J Virol, March 1998, p. 2541-2543, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Heterosexual Transmission of a Murine AIDS
Virus
Yoshiaki
Okada,
Eri
Abe,
Katsutoshi
Komuro, and
Toshiaki
Mizuochi*
Department of Bacterial and Blood Products
and Department of Safety Research on Biologics, National Institute
of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo 162, Japan
Received 2 June 1997/Accepted 3 December 1997
 |
ABSTRACT |
Heterosexual transmission of a murine leukemia virus mixture named
LP-BM5 MuLV, which is known as the murine AIDS virus, was investigated.
Our results indicated that the heterosexual transmission of LP-BM5 MuLV
occurs in both directions with high frequency and that the frequencies
of virus transmission in the cervix and penis are higher than those in
other genital organs. The results suggested that infection by LP-BM5
MuLV via heterosexual transmission may initially take place at
particular retrovirus-sensitive sites (cells) in the genital organs.
 |
TEXT |
Human immunodeficiency virus (HIV)
infection is now pandemic. In many countries, HIV has been spread
mainly by heterosexual transmission (3, 5). For the
prevention of HIV infection, as well as for the development of vaccines
against HIV, it is of a great importance to understand the mechanisms
of the heterosexual transmission of retroviruses. Since it is difficult
to investigate the mechanisms of heterosexual transmission of HIV in
humans experimentally, an animal model with a retrovirus which induces
an acquired immunodeficiency syndrome like human AIDS would be useful.
A murine leukemia virus mixture called LP-BM5 MuLV induces a severe
acquired immunodeficiency syndrome termed murine AIDS (MAIDS) in
susceptible strains of mice (10). The mixture includes a
replication-competent ecotropic virus, mink cell focus-inducing virus,
and a replication-defective virus which has been considered to be
involved in the pathogenesis of MAIDS (4). With many
similarities to human AIDS patients, mice infected with the LP-BM5 MuLV
mixture develop splenomegaly, systemic lymphadenopathy, and severe
immunodeficiency (4, 11). We previously reported that
maternal transmission of LP-BM5 MuLV occurs via mother's milk with
high frequency (12). In the present study, we demonstrate
that the heterosexual transmission of LP-BM5 MuLV also occurs with high
frequency via genital organs.
C57BL/10 (B10) mice were purchased from Japan SLC Inc., Shizuoka,
Japan. All mice were specific-pathogen free and were housed in an
air-conditioned room. They were given autoclaved water and sterilized
pelleted feed. An SC-1 clone chronically infected with LP-BM5 MuLV, the
G6 cell line, was kindly supplied by H. C. Morse III, National
Institutes of Health, Bethesda, Md. Virus was prepared from the
supernatant of G6 cells as previously described (12). The
virus preparation was stored at
70°C until use. B10 mice were
inoculated by the intraperitoneal route with 0.3 ml of the LP-BM5 MuLV
preparation. To increase the frequency of sexual contacts and to avoid
pregnancy in the female mice, all male mice were sterilized by
vasectomy under anesthesia with pentobarbital (Nembutal). The
vasectomized male mice were mated with female mice at least 4 weeks
postoperation, since sperm are usually kept alive for 2 to 3 weeks in
spermiducts. Excised genital organs were crushed with plastic sticks in
1 ml of lysis buffer containing 10 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1 mM EDTA, 0.5% sodium dodecyl sulfate, and proteinase K (0.5 mg/ml).
Spleen cells were lysed after hemolysis with 0.83% NH4Cl.
Lysed samples were incubated at 50°C for 3 h. DNA was extracted
three times with phenol-chloroform, precipitated with cold ethanol,
treated with RNase and proteinase K, and dissolved in 0.1 ml of
H2O. LP-BM5 MuLV defective virus genome was detected by
Southern blot hybridization combined with PCR as described previously
(12). In brief, template DNAs (1 µg per tube) were added
to a cocktail adjusted to final concentrations of 10 mM Tris-HCl (pH
8.3), 50 mM KCl, 1.5 mM MgCl2, 0.01% gelatin, 200 µM
deoxynucleoside triphosphate, 100 pmol of each primer
(5'-CCTCTTCCTTTATCGACACT-3' [sense] and
5'-ATTAGGGGGGGAATAGCTCG-3' [antisense]), and 2 U of Taq DNA polymerase (Boehringer Mannheim) in a total volume
of 100 µl and were subjected to 32 cycles of amplification. In each cycle of PCR, the mixture was denatured at 95°C for 1 min (5 min for
the first cycle), annealed at 55°C for 3 min, and extended at 72°C
for 1 min. The PCR-amplified products were subjected to gel
electrophoresis (1.5% agarose) and transferred to a Hybond N+ membrane
(Amersham) by the alkaline blotting method. Hybridization was achieved
with a 5' 32P-labeled probe
(5'-TGTCAAAGGGACCAGTTAAG-3') at 45°C overnight in 6× SSC
(1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.5% sodium
dodecyl sulfate-100 µg of salmon sperm DNA per ml. Hybridized membranes were washed twice in 2× SSC at 37°C for 10 min and then in
0.5× SSC at 45°C for 30 min. DNA derived from uterine cervices of
uninfected mice was used as a negative control. The limit of sensitivity was approximately 10 copies per tube, as assessed by
Southern blot analysis with plasmid DNAs (1/10 of the PCR product).
Concanavalin A (ConA) was obtained from Pharmacia Fine Chemicals,
Uppsala, Sweden. Responder spleen cells (2 × 105)
were cultured with ConA (5 µg/ml) in 96-well flat-bottomed
microculture plates in 0.2 ml of culture medium at 37°C in 7.5%
CO2. The culture medium consisted of RPMI 1640 supplemented
with 10% fetal calf serum, penicillin (5,000 IU/100 ml), streptomycin
(5,000 µg/100 ml), nonessential amino acids, sodium pyruvate (11.0 mg/100 ml), 2-mercaptoethanol (5 × 10
5 M), and
L-glutamine (29.2 mg/100 ml). On day 2, cultures were pulsed with 1 µCi of [3H]thymidine and incubated for an
additional 12 to 18 h. Incorporation of
[3H]thymidine into responder spleen cells was quantitated
by liquid scintillation counting. Determinations were performed in
triplicate; standard errors of the means were generally <5% and
therefore have not been indicated.
As illustrated in Fig. 1, in order to
investigate the heterosexual transmission of LP-BM5 MuLV from male to
female mice, normal male mice were inoculated with LP-BM5 MuLV and
vasectomized 1 week later. At 5 weeks after virus inoculation, they
were mated with uninfected female mice. After 8 weeks of breeding,
female mice were sacrificed and their vaginae, cervices uteri, corpora uteri, inguinal lymph nodes, and spleens were removed and stored at
70°C until use. In the opposite direction, to investigate virus
transmission from female to male, normal female mice were inoculated
with LP-BM5 MuLV and then mated with uninfected, vasectomized male mice
as described above. After 8 weeks of breeding, male mice were
sacrificed and their penes, prepuces, inguinal lymph nodes and spleens
were removed and stored at
70°C until use. Figure
2 shows the detection by PCR of the
LP-BM5 defective virus genome in genital organs and spleens that were
taken from mice mated with their virus-infected counterparts. It was
demonstrated that although the defective virus genome was detected in
both spleens and genital organs in some male mice (2 of 17 [see Table 1]), as shown in Fig. 2, lanes 3 and 4, the defective virus genome was
detected only in the genital organs, not the spleens (Fig. 2, lanes 5 and 6), from most of the male mice. In contrast, all of the female mice
were positive for defective virus genome only in the genital organs
(Fig. 2, lanes 1 and 2). None of the mice examined were positive for
the virus genome only in the spleens (this issue is discussed below).
It should be noted here that the efficacy of PCR amplification, which
was measured by experiments using the mixture of genomic DNA and
plasmid DNA containing the defective virus, did not differ among
the genital organs and spleens. By using the above strategy, the
heterosexual transmission of LP-BM5 MuLV was investigated according to
the protocol shown in Fig. 1.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Experimental design for examination of heterosexual
transmission of the MAIDS virus in B10 mice. i.p., intraperitoneal.
|
|

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 2.
Detection of the LP-BM5 MuLV defective virus genome by
PCR in genital organs and spleens. The template DNAs (1 µg) derived
from female or male mice which were bred with LP-BM5 MuLV-infected mice
were amplified by PCR. Samples were prepared from either female (lanes
1 and 2) or male (lanes 3 to 6) mice. Lanes 1, 3, and 5, spleen; lane
2, uterine cervix; lanes 4 and 6, penis (from two representative male
mice). The PCR products (5 µl) were applied to a 1.5% agarose gel
and analyzed by Southern blotting with a probe for the defective virus
(12).
|
|
Twenty-five female mice that were mated with the virus-infected male
mice were analyzed for the presence of LP-BM5 defective genome in their
genital organs, lymph nodes, and spleens. As summarized in Table
1, the defective virus genome was
detected with high frequency in cervices (9 of 25). However, the
defective virus genome was not detected in spleens at all (0 of 25).
The female genital organs are divided into three parts, namely, the
vagina, cervix of uterus, and corpus of uterus. As also shown in Table 1, the cervix appears to be more sensitive to virus infection than the
other organs. Since MAIDS virus was not detected in castrated female
mice, which were kept with virus-infected male mice in the same
cage, the virus infection occurred via heterosexual transmission rather
than by nonheterosexual horizontal transmission (data not shown).
In 17 male mice mated with the virus-infected female mice (Table 1),
the defective virus genome was detected in penes with high frequency
(11 of 17). The defective virus genome was detected in DNA prepared
from spleens with much lower frequency (2 of 17). In male mice, the
penis seems to be much more sensitive to virus infection than are the
prepuce and spleen (Table 1). In experiments 1 and 3, we also examined
the inguinal lymph nodes from 16 female mice and 8 male mice. The
defective virus genome was detected in some of the male mice (3 of 8)
but not at all in the female mice examined. These results suggest that
the LP-BM5 MuLV mixture initially infects the cervix or penis and then
spreads over the whole body, including the lymph nodes and spleen.
To determine whether mice infected with LP-BM5 MuLV by heterosexual
transmission in fact develop MAIDS, we examined both spleen weights and
mitogen (ConA) responses of female mice at 10 months after mating. As
shown in Table 2, female mice which were
infected with LP-BM5 MuLV by heterosexual transmission (i.e., the
defective virus genome was detected in the cervix) developed MAIDS as
assessed by splenomegaly and decreased mitogen response, although the
symptoms were less severe than of mice directly infected with LP-BM5
MuLV via the intraperitoneal route. Therefore, the cells in the genital organs were not only infected by the MAIDS virus but also able to
replicate and spread the virus.
The main route of HIV infection is heterosexual transmission (3,
5). However, the mechanisms of heterosexual transmission of
retroviruses have been ill defined. HIV infection has been thought to
occur during sexual contacts through slight injuries in the genital
organs and to subsequently spread over the whole body. Among the
genital organs of females, the parts of direct contact with male
genital organs and semen are the vagina and cervix of uterus. The
vagina is covered by a thick stratified squamous epithelium, while the
cervix is covered by a monolayer columnar epithelium in addition to a
squamous epithelium (2, 7). Histological examination
(13) showed the presence of HIV-infected cells in the
cervices derived from HIV carrier females (those infected with HIV by
drug injections rather than by heterosexual transmission). Furthermore,
a previous study utilizing female chimpanzees demonstrated that
transmission of HIV could occur by insertion of cotton containing HIV
into the vagina (8). These results suggested the presence of
retrovirus-sensitive cells in genital organs. In our study, the cervix
and penis are shown to be sensitive sites for virus infection (Table
1). Our assumption that there might be retrovirus-sensitive cells in a
particular genital organ is currently under investigation by using in
situ hybridization and immunohistochemical analyses.
The heterosexual LP-BM5 MuLV infection rate for females to males
appeared to be higher than that for males to females (Table 1). The
mating frequency of normal male mice with infected female mice is
supposed to be higher than that of normal female mice with infected
male mice, since normal female mice fall into false pregnancy after
mating and therefore reject male mice for a few weeks. This difference
may also be attributed to the longer retention of genital secretions
containing LP-BM5 MuLV in the male genital organs because of their
phimoses (9). In fact, the defective virus genome was
detected in vaginal secretions (both in secreted fluid and cells) by
PCR (data not shown). Alternatively, the penis might be a highly
sensitive site for retrovirus infection. In this regard, it is
interesting that the defective virus genome was detected with very low
frequency (1 of 17 male mice) in the prepuce even though it is
constantly in contact with the penis. It is worth mentioning that
contamination by retroviruses in the seminal fluid may happen at the
prostate, seminal vesicle, vas deferens, Cowper's glands, or penile
urethra, since the sterilized (vasectomized) mice were still capable of
transmitting the viruses to female mice (1, 6).
The animal model for heterosexual transmission of retroviruses
presented here has practical advantages, including (i) the high
frequency of virus transmission and (ii) the possibility of rapid and
cost-effective screening for antiretroviral agents (drugs and vaccines,
etc.). This model may provide valuable information relating to
heterosexual transmission of retroviruses including HIV and may further
contribute to the prevention of HIV infection and the development of a
remedy for AIDS.
 |
ACKNOWLEDGMENTS |
We thank Junichiro Matsuda for teaching us the vasectomy procedure,
Masahiko Makino for preparing the LP-BM5 MuLV mixture, and Sung-Tae Yee
for critical review of the manuscript.
This work was partly supported by a Grant-in-Aid for Encouragement of
Young Scientists from the Ministry of Education, Science and Culture of
Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Bacterial and Blood Products, National Institute of Infectious
Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo 162, Japan. Phone:
81-3-5285-1111. Fax: 81-3-5285-1150. E-mail:
miz{at}nih.go.jp
 |
REFERENCES |
| 1.
|
Anderson, D. J.,
J. A. Politch,
A. Martinez,
B. J. Van Voorhis,
N. S. Padian, and T. R. O'Brien.
1991.
White blood cells and HIV-1 in semen from vasectomised seropositive men.
Lancet
338:573-574.
|
| 2.
|
Blaustein, A., and A. Sedlis.
1982.
Diseases of the vagina, p. 59-98. In
A. Blaustein (ed.), Pathology of the female genital tract, 2nd ed.
Springer-Verlag, New York, N.Y.
|
| 3.
|
Cameron, D. W.,
I. N. Simonsen,
L. J. D'Costa,
A. R. Ronald,
G. M. Maitha,
M. N. Gakinya,
M. Cheang,
J. O. Ndinya-Achola,
P. Piot,
R. C. Brunham, and F. A. Plummer.
1989.
Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men.
Lancet
ii:403-407.
|
| 4.
|
Chattopadhyay, S. K.,
H. C. Morse III,
M. Makino,
S. K. Ruscetti, and J. W. Hartley.
1989.
Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome.
Proc. Natl. Acad. Sci. USA
86:3862-3866[Abstract/Free Full Text].
|
| 5.
|
Clumeck, N.,
H. Taelman,
P. Hermans,
P. Piot,
M. Schoumacher, and S. De Wit.
1989.
A cluster of HIV infection among heterosexual people without apparent risk factors.
N. Engl. J. Med.
321:1460-1462[Medline].
|
| 6.
|
Da Silva, M.,
M. M. Shevchuk,
W. J. Cronin,
N. A. Armenakas,
M. Tannenbaum,
J. A. Fracchia, and H. L. Ioachim.
1990.
Detection of HIV-related protein in testes and prostates of patients with AIDS.
Am. J. Clin. Pathol.
93:196-201[Medline].
|
| 7.
|
Frenczy, A.
1982.
Anatomy and histology of the cervix, p. 119-135. In
A. Blaustein (ed.), Pathology of the female genital tract, 2nd ed.
Springer-Verlag, New York, N.Y.
|
| 8.
|
Fultz, P. N.,
H. M. McClure,
H. Daugharty,
A. Brodie,
C. R. McGrath,
B. Swenson, and D. P. Francis.
1986.
Vaginal transmission of human immunodeficiency virus (HIV) to a chimpanzee.
J. Infect. Dis.
154:896-900[Medline].
|
| 9.
|
Kreiss, J. K., and S. G. Hopkins.
1993.
The association between circumcision status and human immunodeficiency virus infection among homosexual men.
J. Infect. Dis.
168:1404-1408[Medline].
|
| 10.
|
Mosier, D. E.
1986.
Animal models for retrovirus-induced immunodeficiency.
Immunol. Investig.
15:233-261[Medline].
|
| 11.
|
Mosier, D. E.,
R. A. Yetter, and H. C. Morse, III.
1985.
Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/10 mice.
J. Exp. Med.
161:766-784[Abstract/Free Full Text].
|
| 12.
|
Okada, Y.,
K. Suzuki,
K. Komuro, and T. Mizuochi.
1992.
High frequency of transmission of murine AIDS virus in C57BL/10 mice via mother's milk.
J. Virol.
66:5177-5182[Abstract/Free Full Text].
|
| 13.
|
Pomerantz, R. J.,
S. M. de la Monte,
S. P. Donegan,
T. R. Rota,
M. W. Vogt,
D. E. Craven, and M. S. Hirsh.
1988.
Human immunodeficiency virus (HIV) infection of the uterine cervix.
Ann. Intern. Med.
108:321-327.
|
J Virol, March 1998, p. 2541-2543, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.